9 research outputs found
Logistic or not Logistic?
We propose a new class of goodness-of-fit tests for the logistic distribution based on a characterization related to the density approach in the context of Stein\u27s method. This characterization-based test is a first of its kind for the logistic distribution. The asymptotic null distribution of the test statistic is derived and it is shown that the test is consistent against fixed alternatives. The finite sample power performance of the newly proposed class of tests is compared to various existing tests by means of a Monte Carlo study. It is found that this new class of tests are especially powerful when the alternative distributions are heavy tailed, like Student\u27s t and Cauchy, or for skew alternatives such as the log-normal, gamma and chi-square distributions
Determinants of the adoption of virtual team collaboration as a mode of knowledge transfer within innovation driven organisations
Society 5.0 seeks to resolve social and economic imbalances through the integration of the virtual world and the physical world. Amid the COVID-19 pandemic the need and possibilities hereof has become so much clearer. This paper aims to shed light on the factors affecting the adoption of virtual team collaboration within innovation driven companies, as their primary mode of knowledge transfer. By getting insight into these factors, we will be on our way to enable individuals, companies and governments to promote effective adoption of virtual team collaboration. This in turn can reduce the knowledge gap that exists in developing post-colonial countries, by enabling knowledge to be better transferred between industries within the country and from outside the country. This paper provides an in-depth coverage of the existing literature starting by looking into knowledge transfer as a management principle, then looking at the innovation of virtual team collaboration itself and finally at the social system, an innovation driven organisation, into which the innovation will be adopted. The findings are then applied to the Diffusion of Innovation theory’s Innovation-Decision Process. By understanding these key determinants, organisations may utilise this guidance in the application of virtual team collaboration (VTC) as a mode of knowledge transfer when considering innovation.https://www.springer.com/series/78992022-09-24hj2021Graduate School of Technology Management (GSTM)Informatic
Effects of egg as an early complementary food on growth of 6- to 9-month-old infants: a randomised controlled trial
Abstract
Objective:
To assess the effect of daily egg consumption for six months on linear growth (primary outcome), weight-for-age, weight-for-length, mid-upper arm circumference-for-age, head circumference-for-age Z-scores, gross motor milestones development, anaemia and iron status (secondary outcomes) in a low socioeconomic community.
Participants:
Infants aged 6 to 9 months living in the peri-urban Jouberton area, in the Matlosana Municipality, South Africa.
Design:
A randomised controlled trial with a parallel design was implemented. Eligible infants were randomly allocated to the intervention (n 250) receiving one egg/day and the control group (n 250) receiving no intervention. The participants were visited weekly to monitor morbidity and gross motor development, with information on adherence collected for the intervention group. Trained assessors took anthropometric measurements, and a blood sample was collected to assess anaemia and iron status. There was blinding of the anthropometric assessors to the groups during measurements and the statistician during the analysis.
Results:
Baseline prevalence of stunting, underweight, wasting, overweight and anaemia was 23·8 %, 9·8 %, 1·2 %, 13·8 % and 29·2 %, respectively, and did not differ between groups. Overall, 230 and 216 participants in the intervention and control groups completed the study, respectively. There was no intervention effect on length-for-age, weight-for-age, weight-for-length Z-scores, gross motor milestone development, anaemia and iron status.
Conclusions:
Daily egg intake did not affect linear growth, underweight, wasting, motor milestones development, anaemia and iron status. Other interventions are necessary to understand the effect of animal-source food intake on children’s growth and development. This trial was registered at https://clinicaltrials.gov/ (NCT05168085)
Association of egg intake with blood lipids, cardiovascular disease, and mortality in 177,000 people in 50 countries
BACKGROUND: Eggs are a rich source of essential nutrients, but they are also a source of dietary cholesterol. Therefore, some guidelines recommend limiting egg consumption. However, there is contradictory evidence on the impact of eggs on diseases, largely based on studies conducted in high-income countries.
OBJECTIVES: Our aim was to assess the association of egg consumption with blood lipids, cardiovascular disease (CVD), and mortality in large global studies involving populations from low-, middle-, and high-income countries.
METHODS: We studied 146,011 individuals from 21 countries in the Prospective Urban Rural Epidemiology (PURE) study. Egg consumption was recorded using country-specific validated FFQs. We also studied 31,544 patients with vascular disease in 2 multinational prospective studies: ONTARGET (Ongoing Telmisartan Alone and in Combination with Ramipril Global End Point Trial) and TRANSCEND (Telmisartan Randomized Assessment Study in ACEI Intolerant Subjects with Cardiovascular Disease). We calculated HRs using multivariable Cox frailty models with random intercepts to account for clustering by study center separately within each study.
RESULTS: In the PURE study, we recorded 14,700 composite events (8932 deaths and 8477 CVD events). In the PURE study, after excluding those with history of CVD, higher intake of egg (≥7 egg/wk compared with/wk intake) was not significantly associated with blood lipids, composite outcome (HR: 0.96; 95% CI: 0.89, 1.04; P-trend = 0.74), total mortality (HR: 1.04; 95% CI: 0.94, 1.15; P-trend = 0.38), or major CVD (HR: 0.92; 95% CI: 0.83, 1.01; P-trend = 0.20). Similar results were observed in ONTARGET/TRANSCEND studies for composite outcome (HR 0.97; 95% CI: 0.76, 1.25; P-trend = 0.09), total mortality (HR: 0.88; 95% CI: 0.62, 1.24; P-trend = 0.55), and major CVD (HR: 0.97; 95% CI: 0.73, 1.29; P-trend = 0.12).
CONCLUSIONS: In 3 large international prospective studies including ∼177,000 individuals, 12,701 deaths, and 13,658 CVD events from 50 countries in 6 continents, we did not find significant associations between egg intake and blood lipids, mortality, or major CVD events. The ONTARGET and TRANSCEND trials were registered at clinicaltrials.gov as NCT00153101. The PURE trial was registered at clinicaltrials.gov as NCT03225586